{"pmid":32376422,"pmcid":"PMC7196541","title":"Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","text":["Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.","J Am Acad Dermatol","Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata","32376422"],"journal":"J Am Acad Dermatol","authors":["Rudnicka, Lidia","Goldust, Mohamad","Glowacka, Paulina","Sikora, Mariusz","Sar-Pomian, Marta","Rakowska, Adriana","Samochocki, Zbigniew","Olszewska, Malgorzata"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376422","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.153","keywords":["covid-19","autoimmune disease","cyclosporine","dermatology","immunosuppressants","virus"],"e_drugs":["Cyclosporine"],"topics":["Treatment"],"weight":1,"_version_":1666596532358479872,"score":9.490897,"similar":[{"pmid":32344070,"pmcid":"PMC7194643","title":"Calm before the storm: understanding the role of JAK inhibitors in COVID-19.","text":["Calm before the storm: understanding the role of JAK inhibitors in COVID-19.","J Am Acad Dermatol","Peterson, Danielle","Damsky, William","King, Brett","32344070"],"journal":"J Am Acad Dermatol","authors":["Peterson, Danielle","Damsky, William","King, Brett"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344070","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jaad.2020.04.097","keywords":["covid-19","jak","janus kinase inhibitors","sars-cov-2","autoimmune disease","coronavirus","general dermatology","immunomodulators","immunosuppressants","medical dermatology"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495041667074,"score":99.92316},{"pmid":32278797,"pmcid":"PMC7144601","title":"The use of Janus kinase inhibitors in the time of SARS-CoV-2.","text":["The use of Janus kinase inhibitors in the time of SARS-CoV-2.","J Am Acad Dermatol","Peterson, Danielle","Damsky, William","King, Brett","32278797"],"journal":"J Am Acad Dermatol","authors":["Peterson, Danielle","Damsky, William","King, Brett"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278797","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.03.099","keywords":["covd-19","janus kinase inhibitors","sars-cov-2","autoimmune disease","coronavirus","general dermatology","immunomodulators","immunosuppressants","medical dermatology"],"topics":["Treatment"],"weight":1,"_version_":1666138491589754880,"score":99.311676},{"pmid":32393973,"title":"Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.","text":["Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.","First detected in Wuhan, China, the novel 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped RNA beta-coronavirus responsible for an unprecedented, worldwide pandemic caused by COVID-19. Optimal management of immunosuppression in inflammatory bowel disease (IBD) patients with COVID-19 infection currently is based on expert opinion, given the novelty of the infection and the corresponding lack of high-level evidence in patients with immune-mediated conditions. There are limited data regarding IBD patients with COVID-19 and no data regarding early pregnancy in the era of COVID-19. This article describes a patient with acute severe ulcerative colitis (UC) during her first trimester of pregnancy who also has COVID-19. The case presentation is followed by a review of the literature to date on COVID-19 in regard to inflammatory bowel disease and pregnancy, respectively.","Inflamm Bowel Dis","Rosen, Melissa H","Axelrad, Jordan","Hudesman, David","Rubin, David T","Chang, Shannon","32393973"],"abstract":["First detected in Wuhan, China, the novel 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped RNA beta-coronavirus responsible for an unprecedented, worldwide pandemic caused by COVID-19. Optimal management of immunosuppression in inflammatory bowel disease (IBD) patients with COVID-19 infection currently is based on expert opinion, given the novelty of the infection and the corresponding lack of high-level evidence in patients with immune-mediated conditions. There are limited data regarding IBD patients with COVID-19 and no data regarding early pregnancy in the era of COVID-19. This article describes a patient with acute severe ulcerative colitis (UC) during her first trimester of pregnancy who also has COVID-19. The case presentation is followed by a review of the literature to date on COVID-19 in regard to inflammatory bowel disease and pregnancy, respectively."],"journal":"Inflamm Bowel Dis","authors":["Rosen, Melissa H","Axelrad, Jordan","Hudesman, David","Rubin, David T","Chang, Shannon"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393973","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1093/ibd/izaa109","keywords":["covid-19","coronavirus","cyclosporine","inflammatory bowel disease","pregnancy","ulcerative colitis"],"locations":["Wuhan","China","Optimal"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666627827824328706,"score":54.65207},{"pmid":32502509,"title":"The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.","text":["The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.","J Infect","Liu, Ming","Gao, Ya","Zhang, Yuejun","Shi, Shuzhen","Chen, Yamin","Tian, Jinhui","32502509"],"journal":"J Infect","authors":["Liu, Ming","Gao, Ya","Zhang, Yuejun","Shi, Shuzhen","Chen, Yamin","Tian, Jinhui"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502509","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jinf.2020.05.065","keywords":["covid-19","meta-analysis","mortality","severity","autoimmune disease"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668804508820439040,"score":54.553974},{"pmid":32360811,"pmcid":"PMC7191273","title":"Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts.","text":["Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts.","Clin Gastroenterol Hepatol","Allocca, Mariangela","Fiorino, Gionata","Zallot, Camille","Furfaro, Federica","Gilardi, Daniela","Radice, Simona","Danese, Silvio","Peyrin-Biroulet, Laurent","32360811"],"journal":"Clin Gastroenterol Hepatol","authors":["Allocca, Mariangela","Fiorino, Gionata","Zallot, Camille","Furfaro, Federica","Gilardi, Daniela","Radice, Simona","Danese, Silvio","Peyrin-Biroulet, Laurent"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360811","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.cgh.2020.04.071","keywords":["covid-19","biologic therapy","immunosuppressants","inflammatory bowel disease"],"locations":["Nancy","Milan"],"countries":["Italy","France"],"countries_codes":["ITA|Italy","FRA|France"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495896256512,"score":52.3868}]}